Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
Nippon Carbon, Jan-Mar (1Q) Ordinary Profit Decreases by 31%
5302 Nippon Carbon Co. , Ltd. 【J-GAAP】
Earnings ReportNippon Carbon Co. , Ltd. <5302> [TSE Prime] announced its financial results after the market closed on May 9th (15:30). The consolidated ordinary profit for the first quarter of the fiscal year ending December 2025 (January to March) dropped 31.3% from the same period last year to 1.2 billion yen. The progress rate toward the plan for the six months ending June (1H) of 3 billion yen was 40.3%, almost the same as the five-year average of 39.2%.
In the most recent three-month period, from January to March (1Q), the operating profit margin decreased from 19.2% in the same period last year to 16.2%.
Kabutan News
Actual Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Progress Rate vs. First Half | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Jan - Mar, 2023 | 7,695 | 1,252 | 1,284 | 752 | 68.2 | 37.6 | May 10, 2023 | J-GAAP |
| Jan - Mar, 2024 | 8,438 | 1,621 | 1,760 | 969 | 87.8 | 46.6 | May 10, 2024 | J-GAAP |
| Jan - Mar, 2025 | 7,958 | 1,289 | 1,209 | 674 | 61.0 | 40.3 | May 9, 2025 | J-GAAP |
| YoY | -5.7% | -20.5% | -31.3% | -30.4% | -30.5% |
Current Period Guidance
H1 Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Jan - Jun, 2024 | 18,800 | 3,393 | 3,775 | 2,292 | 207.5 | 100 | Aug 9, 2024 | J-GAAP |
| Jan - Jun, 2025 Guidance | 20,000 | 3,000 | 3,000 | 1,800 | 162.8 | 100 | Feb 10, 2025 | J-GAAP |
| YoY | +6.4% | -11.6% | -20.5% | -21.5% | -21.5% |
Current Period Guidance
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Dec, 2023 | 37,867 | 6,573 | 7,115 | 4,050 | 366.8 | 200 | Feb 9, 2024 | J-GAAP |
| Dec, 2024 | 37,956 | 6,319 | 6,692 | 4,078 | 369.0 | 200 | Feb 10, 2025 | J-GAAP |
| Dec, 2025 Guidance | 40,000 | 6,500 | 6,800 | 4,100 | 370.8 | 200 | Feb 10, 2025 | J-GAAP |
| YoY | +5.4% | +2.9% | +1.6% | +0.5% | +0.5% |
Quarterly Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Operating Profit Margin | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Jan - Mar, 2024 | 8,438 | 1,621 | 1,760 | 969 | 87.8 | 19.2 | May 10, 2024 | J-GAAP |
| Apr - Jun, 2024 | 10,362 | 1,772 | 2,015 | 1,323 | 119.8 | 17.1 | Aug 9, 2024 | J-GAAP |
| Jul - Sep, 2024 | 8,623 | 1,348 | 1,090 | 595 | 53.9 | 15.6 | Nov 11, 2024 | J-GAAP |
| Oct - Dec, 2024 | 10,533 | 1,578 | 1,827 | 1,191 | 107.8 | 15.0 | Feb 10, 2025 | J-GAAP |
| Jan - Mar, 2025 | 7,958 | 1,289 | 1,209 | 674 | 61.0 | 16.2 | May 9, 2025 | J-GAAP |
| YoY | -5.7% | -20.5% | -31.3% | -30.4% | -30.5% |
Related Articles
SOFTCREATE, 8% Increase in Ordinary Profit, Update Record High for Fifteenth Consecutive Term, Dividend Raised by 7 yen
Central Forest Group, Jan-Mar (1Q) Ordinary Profit Decreases by 20%
Nissha, Jan-Mar (1Q) Net Income Decreases by 93%
AnGes, Jan-Mar (1Q) Net Income Loss Narrows
Asia Air Survey, First Half Ordinary Profit Decreases by 18%
MatsukiyoCocokara, 4% Increase in Ordinary Profit, Update Record High for Fifth Consecutive Term, Increased Previous Year's Dividend by 2 yen, This Fiscal Year to Increase Dividend by 2 yen
TENMA, 22% Decrease in Ordinary Profit for the Last Fiscal Year, Current period performance is undisclosed.
Shizuoka Financial, 16% Increase in Ordinary Profit, Record High for The First Time in Two Years, Dividend Raised by 12 yen
NAGAHORI, 15% Increase in Ordinary Profit for The Current Fiscal Year
TAIKO PHARMA, Jan-Mar (1Q) Ordinary Profit Decreases by 95%